Towards next generation maggot debridement therapy: transgenic Lucilia sericata larvae that produce and secrete a human growth factor

BACKGROUND: Diabetes and its concurrent complications impact a significant proportion of the population of the US and create a large financial burden on the American health care system. FDA-approved maggot debridement therapy (MDT), the application of sterile laboratory-reared Lucilia sericata (gree...

Descripción completa

Detalles Bibliográficos
Autores principales: Linger, Rebecca J., Belikoff, Esther J., Yan, Ying, Li, Fang, Wantuch, Holly A., Fitzsimons, Helen L., Scott, Maxwell J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804476/
https://www.ncbi.nlm.nih.gov/pubmed/27006073
http://dx.doi.org/10.1186/s12896-016-0263-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804476/
https://www.ncbi.nlm.nih.gov/pubmed/27006073
http://dx.doi.org/10.1186/s12896-016-0263-z

Ejemplares similares